Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostatic Neoplasms 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Nerve Tissue 1Neoplasms 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Breast Neoplasms 1

Interventions

Valproic Acid 2Temozolomide 2Magnetic Resonance Spectroscopy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trametinib 1sonidegib 1ribociclib 1mirdametinib 1gallium Ga 68 dotatate 1fluorodopa F 18 1fludarabine phosphate 1fludarabine 1Thiotepa 1Tacrolimus 1Radiotherapy 1Mycophenolic Acid 1Melphalan 1Interleukin-12 1Immunologic Techniques 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Fibroblast Growth Factor 7 1Etoposide 1Doxorubicin 1Cyproheptadine 1Cyclosporins 1Cyclosporine 1Bevacizumab 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Neuroepithelial × Interleukin-12 × Clear all
NCT04388033 2020-06-09

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Unknown
10 enrolled
CNS

Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Neoplasms, Neuroepithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡